A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients
- PMID: 26812488
- PMCID: PMC5872812
- DOI: 10.1007/s00381-015-2983-0
A cross-sectional study of carnitine deficiency and fatigue in pediatric cancer patients
Abstract
Purpose: Carnitine deficiency has been found in cancer patients and has been associated with fatigue. This study aimed to explore the prevalence of carnitine deficiency in pediatric cancer patients and its relationship with fatigue and other potential contributing factors.
Methods: Children with cancer or Langerhans cell histiocytosis who were receiving treatment or had completed therapy were eligible. Patients completed the Pediatric Functional Assessment of Chronic Illness-Fatigue, the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale, a numeric fatigue rating, and had carnitine levels obtained. Carnitine deficiency was defined as a total and/or free carnitine level less than normal for age or an acylcarnitine value higher than normal for age.
Results: Data from 142 children aged 8-17 were analyzed. Twenty-eight of 142 (19.7 %) had decreased total and 42.8 % (12/28) had decreased free carnitine levels. No patients had elevated acylcarnitine levels or elevated ratios. Patients with versus without carnitine deficiency differed by age (p = 0.043), treatment (p = 0.037), duration since last chemotherapy (p = 0.020), and body mass index (p = 0.010), but not fatigue, when all data were analyzed together. Yet, a negative relationship between fatigue and carnitine levels was found on a subgroup (off-therapy; fatigue worse than the norm).
Conclusion: No significant association between fatigue and carnitine level was demonstrated when data from all patients were analyzed together; however, a significant yet unexpected relationship was found for patients who completed therapy and reported elevated fatigue. Given the small sample size, these results should be interpreted with caution. Future studies to explore impact upon excessive carnitine levels are warranted.
Keywords: Cancer; Carnitine; Children; Fatigue.
Conflict of interest statement
Figures
Similar articles
-
Carnitine plasma levels and fatigue in children/adolescents receiving cisplatin, ifosfamide, or doxorubicin.J Pediatr Hematol Oncol. 2009 Sep;31(9):664-9. doi: 10.1097/MPH.0b013e3181b259a7. J Pediatr Hematol Oncol. 2009. PMID: 19707160
-
Fatigue and carnitine levels over multiple cycles of chemotherapy in children and adolescents.Eur J Oncol Nurs. 2015 Feb;19(1):7-12. doi: 10.1016/j.ejon.2014.07.015. Epub 2014 Sep 30. Eur J Oncol Nurs. 2015. PMID: 25260954
-
Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study.J Pain Symptom Manage. 2006 Dec;32(6):551-9. doi: 10.1016/j.jpainsymman.2006.09.001. J Pain Symptom Manage. 2006. PMID: 17157757 Clinical Trial.
-
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.Nutrition. 2006 Feb;22(2):136-45. doi: 10.1016/j.nut.2005.06.003. Nutrition. 2006. PMID: 16459226
-
Quality of life and clinical decisions in chemotherapy-induced anemia.Oncology (Williston Park). 2006 Jul;20(8 Suppl 6):25-8. Oncology (Williston Park). 2006. PMID: 16925108 Review.
Cited by
-
The predictive trifecta? Fatigue, pain, and anxiety severity forecast the suffering profile of children with cancer.Support Care Cancer. 2022 Mar;30(3):2081-2089. doi: 10.1007/s00520-021-06622-x. Epub 2021 Oct 18. Support Care Cancer. 2022. PMID: 34661748 Free PMC article.
-
l-Carnitine and Acetyl-l-Carnitine Induce Metabolism Alteration and Mitophagy-Related Cell Death in Colorectal Cancer Cells.Nutrients. 2025 Mar 13;17(6):1010. doi: 10.3390/nu17061010. Nutrients. 2025. PMID: 40290068 Free PMC article.
-
Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation.Oxid Med Cell Longev. 2023 Aug 10;2023:9328344. doi: 10.1155/2023/9328344. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 37600065 Free PMC article. Review.
-
Symptoms in Children Receiving Treatment for Cancer-Part I: Fatigue, Sleep Disturbance, and Nausea/Vomiting.J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):244-261. doi: 10.1177/1043454219849576. J Pediatr Oncol Nurs. 2019. PMID: 31307321 Free PMC article. Review.
References
-
- Henry D, Viswanathan HN, Elkin E, Traina S, Wade S, Cella D. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer. 2008;16:791–801. - PubMed
-
- Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12:4–10. - PubMed
-
- Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100:1155–1166. - PubMed
-
- Morrow GR. Cancer-related fatigue: causes, consequences, and management. Oncologist. 2007;12:1–3. - PubMed
-
- Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12:22–34. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical